Select Language
VP3
VP3 Product List
- Product Category
Protein (5)
- Product Status
Launched (5)
- Species
Adeno-associated virus 2 (1)Adeno-associated virus 6 (1)Adeno-associated virus 5 (1)Adeno-associated virus 8 (1)Adeno-associated virus 9 (1)
- Tag
His Tag (5)
- Conjugate
Unconjugated (5)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
HOT VP3-A5146 | Adeno-associated virus 6 | E. coli | AAV6 VP3, Recombinant Protein |  | ||
HOT VP3-A5147 | Adeno-associated virus 5 | E. coli | AAV5 VP3, Recombinant Protein |  | | |
HOT VP3-A5149 | Adeno-associated virus 9 | E. coli | AAV9 VP3, Recombinant Protein |  | | |
VP3-A5145 | Adeno-associated virus 2 | E. coli | AAV2 VP3, Recombinant Protein |  | |  |
VP3-A5148 | Adeno-associated virus 8 | E. coli | AAV8 VP3, Recombinant Protein |  | |
Total: 5
- 1
VP3 Background
Adeno-associated virus is a single-stranded DNA virus and the current scientific consensus is that it does not cause any human disease. It consists of a protein capsid (CAPside) and a 4.7 KB length single stranded DNA genome. The protein capsid consists of three subunits, VP1, VP2, and VP3.
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Gefurulimab | TPP-2511; ALXN-1720; CON-9978 | Phase 3 Clinical | Alexion Pharmaceuticals Inc | Myasthenia Gravis; Proteinuria | Details |
| Izokibep | IMG-020; IMG020; ABY-035; AFB-035 | Phase 3 Clinical | Affibody Ab | Spondylitis, Ankylosing; Psoriasis; Arthritis, Psoriatic; Hidradenitis Suppurativa; Uveitis; Plaque psoriasis | Details |
| Albumin(King Edward Medical University) | Phase 3 Clinical | King Edward Medical University | Burns | Details | |
| Hyperoncotic human albumin | Phase 3 Clinical | Manchester University Nhs Foundation Trust | Shock, Septic; Sepsis; Shock | Details | |
| MK-6070 | HPN-328; MK-6070 | Phase 2 Clinical | Harpoon Therapeutics | Small Cell Lung Carcinoma; Carcinoma, Neuroendocrine | Details |
| Human Albumin (European Foundation for Study of Chronic Liver Failure) | Phase 2 Clinical | European Foundation For Chronic Liver Failure | Liver Cirrhosis | Details | |
| Human albumin (Baylor College of Medicine) | Phase 2 Clinical | Baylor College Of Medicine | Ascites | Details | |
| Human albumin（Albimmune） | Phase 2 Clinical | Shock, Septic | Details | ||
| Tarperprumig | ALXN-1820 | Phase 2 Clinical | Alexion Pharmaceuticals Inc | Anemia, Sickle Cell | Details |
| ND-021 | ND-021; NM21-1480; CS-2006; CS2006 | Phase 1 Clinical | Numab Therapeutics Ag, Cstone Pharmaceuticals | Solid tumours; Carcinoma; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Carcinoma, Ovarian Epithelial; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung | Details |
| Albumin(Tianjin Huanhu Hospital) | Phase 1 Clinical | Tianjin Huanhu Hospital | Arterial Occlusive Diseases; Hypoproteinemia | Details |
Marketed Drug Information
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Human albumin (Hebei Da'an Pharmaceutical) | Approved | Hebei Daan Pharmaceutical Co Ltd | Mainland China | Respiratory Distress Syndrome, Adult; Fibrosis; Shock, Hemorrhagic | Hebei Daan Pharmaceutical Co Ltd | 2002-01-31 | Fibrosis; Respiratory Distress Syndrome, Adult; Shock, Hemorrhagic | Details | ||
| 20% Human albumin (Hemarus Therapeutics) | Approved | Hemarus Therapeutics | Hemalb | India | Respiratory Distress Syndrome, Adult; Nephrotic Syndrome; Hypoalbuminemia; Hypovolemia | Hemarus Therapeutics | 2015-08-01 | Hypovolemia; Respiratory Distress Syndrome, Adult; Hypoalbuminemia; Nephrotic Syndrome | Details | |
| Human albumin (Guizhou Taibang Biological Products) | Approved | Guizhou Taibang Biological Products Co Ltd | Mainland China | Respiratory Distress Syndrome, Adult; Fibrosis; Shock, Hemorrhagic | Guizhou Taibang Biological Products Co Ltd | 1998-01-01 | Fibrosis; Respiratory Distress Syndrome, Adult; Shock, Hemorrhagic | Details | ||
| Ozoralizumab | PF-5230896; ATN-103; PF-05230896; TS-152 | Approved | Ablynx Nv | ナノゾラ, Nanozora | Japan | Arthritis, Rheumatoid | Taisho Pharmaceutical Co Ltd | 2022-09-26 | Arthritis, Rheumatoid | Details |
| Human albumin (Hualan Biological Engineering) | Approved | Hualan Genetic Engineering Co Ltd | Mainland China | Hemorrhage; Hypovolemia; Anemia, Hemolytic, Autoimmune; Hypoalbuminemia | Hualan Genetic Engineering Co Ltd | 1995-01-01 | Hypovolemia; Hemorrhage; Anemia, Hemolytic, Autoimmune; Hypoalbuminemia | Details | ||
| Human Albumin(Guangdong Danxia) | Approved | Guangdong Danxia Biological Pharmaceutical Co Ltd | Mainland China | Hypovolemia | Guangdong Danxia Biological Pharmaceutical Co Ltd | 2012-10-30 | Hypovolemia | Details | ||
| Human Albumin(Anhui Da'An) | Approved | Tonrol Bio-Pharmaceutical Co Ltd | Mainland China | Tonrol Bio-Pharmaceutical Co Ltd | 2002-01-31 | Details | ||||
| Human Albumin(Huhan Nanyue) | Approved | Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd | Mainland China | Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd | 1994-01-01 | Details | ||||
| Human albumin(Tonrol Bio-Pharmaceutical) | Approved | Tonrol Bio-Pharmaceutical Co Ltd | Mainland China | Hypovolemia | Tonrol Bio-Pharmaceutical Co Ltd | 1996-01-01 | Hypovolemia | Details | ||
| Human Albumin (SK Plasma) | Approved | Sk Plasma Co Ltd | Mainland China | Sk Plasma Co Ltd | 2010-03-15 | Details | ||||
| Human Serum Albumin (Green Cross) | Approved | Green Cross China Biological Products Co Ltd | Mainland China | Hypovolemia | Green Cross China Biological Products Co Ltd | 1998-01-01 | Hypovolemia | Details | ||
| Albumin Human(Cis Bio International) | Approved | Cis Bio International Sa | Pulmocis | EU | Cis Bio International Sa | 2020-04-06 | Details | |||
| Perfluoropropane human albumin microspheres(Hunan Jingda) | Approved | Hunan kangrun Pharmaceutical Co Ltd | Mainland China | Contrast agents | Hunan kangrun Pharmaceutical Co Ltd | 2008-10-13 | Liver Diseases; Contrast agents | Details | ||
| Albumin Human(Sanquin Plasma Products) | Approved | Sanquin Plasma Products Bv | Details | |||||||
| Albumin Human (Biotest Pharma GmbH) | Approved | Biotest Pharma Gmbh | Albiomin, Albiomin 5%, Albiomin 10% | EU | Biotest Pharma Gmbh | 2008-12-18 | Hypovolemia | Details | ||
| Human albumin(Gailifu Pharmaceutical Technology) | Approved | Grifols Medical Consulting(Shanghai)Co Ltd | Mainland China | Shock, Hemorrhagic; Edema; Ascites; Pharmaceutical aids; Hypoproteinemia; Hyperbilirubinemia, Neonatal; Respiratory Distress Syndrome, Adult; Burns; Hypovolemia; Intracranial Hypertension | Grifols Medical Consulting(Shanghai)Co Ltd | 2012-01-01 | Hypovolemia; Hypoproteinemia; Hyperbilirubinemia, Neonatal; Shock, Hemorrhagic; Ascites; Respiratory Distress Syndrome, Adult; Pharmaceutical aids; Burns; Intracranial Hypertension; Edema | Details | ||
| Vialebex (LFB SA/Swedish Orphan Biovitrum AB) | Approved | Lfb Biotechnologies Sas, Swedish Orphan Biovitrum Ag | France | Hypotension; Shock | null | 2013-02-01 | Hypotension; Shock | Details |
- Product List
- Marketed Drug Information
- Clinical Drug Information
Share to:
Online Message
Contact Us
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호